All News & Stories
Piloting a FLASH Radiotherapy Beam for Treatment of Cancer
Researchers convert a standard linear accelerator used for radiation therapy, to deliver an ultra-high-dose rate beam to cancer patients “in a flash.”
Cancer Care Close to Home: New Hampshire’s Only NCI-Designated Comprehensive Cancer Center Expands Cancer Services in Southern New Hampshire
Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center will open two new specialty clinics, NeuroOncology and Gynecologic Oncology, at their Dartmouth-Hitchcock location at the Catholic Medical Center’s Notre Dame Pavilion in Manchester.
COVID-19 Vaccine FAQ for Norris Cotton Cancer Center Patients
Read answers to frequently asked questions related to the safety and efficacy of the COVID-19 vaccine for patients undergoing treatment for cancer.
Lionel D. Lewis, MD, Elected as a 2020 Fellow of the British Pharmacological Society
Dr. Lewis elected for prestigious fellowship for his substantial contributions, demonstrated distinction, and peer recognition in clinical pharmacology and therapeutics.
Dartmouth-Hitchcock Health Employees Inspire Historic Multi-Million Dollar Gift
Bill and Sue Conaty pledge $5.25 million in support of Dartmouth-Hitchcock Medical Center’s new Patient Pavilion
Researchers Find Source of Breast Tumor Heterogeneity and Pathway that Limits Emergence
Researchers find a signaling pathway that limits mammary basal cells’ ability to fuel the growth of multiple aggressive cell populations within a breast tumor, uncovering opportunities for novel therapeutic approaches to breast cancer.
Genetic Testing for Breast Cancer
Family history remains on the National Cancer Institute’s list of risk factors for breast cancer, but what does it mean when cancer “runs in the family?"
Norris Cotton Cancer Center Launches New Cellular Therapy Program
NCCC treats the first patients with new CAR T-cell therapy.
Kim Levitch and the Supercharged, Cancer-Killing CAR T-Cells
Kim Levitch becomes the first patient at Norris Cotton Cancer Center to undergo the newest cancer immunotherapy, CAR T-cell therapy.
Clinical Trial of Anti-VISTA Cancer Antibody Therapy Opens for Patient Enrollment
Dartmouth-Hitchcock Norris Cotton Cancer Center leads a new multi-center Phase I in-human clinical trial of anti-VISTA, a therapeutic antibody designed to target a molecule that keeps the immune system quiet against cancer.